PatientView | États-Unis perspectives des groupes de patients : Une place à la table des négociations tarifaires

Objectifs des groupes de patients

Les pourcentages ci-dessous mettent en évidence la manière dont les 91 groupes de patients interagissent avec les régulateurs et défendent les intérêts des patients. Les répondants pouvant être représentés dans plusieurs domaines, les pourcentages peuvent ne pas totaliser 100 %.

interactions

Comment les groupes de patients interagissent avec les régulateurs de médicaments

Découvrez ce que signifient les objectifs

32 mentions

17 mentions

15 mentions

11 mentions

5 mentions

1 mention

actions et plaidoyer

Comment les groupes de patients obtiennent l'accès aux médicaments

Découvrez ce que signifient les objectifs

27 mentions

22 mentions

3 mentions

2 mentions

Texte anglais	Aire thérapeutique	Catégorie	Patients touchés	Portée géographique	Engagement réglementaire	Répondant
Our community members participate in this at an individual level, and as an organisation, we meet with industry policy holders.	Cancer > Cancer : femmes	Partenariat réglementaire > Travailler avec les organismes de réglementation	10 000	International	Rarely	119028011659
We collaborated on an externally-led Patient-Focused Drug Development meeting with the FDA [Food and Drug Administration] in 2025.	Neurologique > Sclérose en plaques	Partenariat réglementaire > Travailler avec les organismes de réglementation	100 000	National	Rarely	119039458452
We engage in education, guidance, and institutional dialogue initiatives to promote informed, equitable decisions that place community well-being at their centre.	Défense des droits des patients > Formation	Partenariat réglementaire > Travailler avec les organismes de réglementation	100 000	International	Regularly	119063146174
Through written comments, sign-on letters, and participating in roundtable meetings where drugs are being discussed.	Cancer > Cancer : sarcome	Partenariat réglementaire > Travailler avec les organismes de réglementation	10 000	International	Sometimes	119064713792
Just recently hosted an EL-PFDD [Externally-Led Patient-Focused Drug Development] meeting and attended FDA [Food and Drug Administration] meetings with industry partners.	Rare > Maladies rares : génétiques	Partenariat réglementaire > Travailler avec les organismes de réglementation	5 000	International	Regularly	119065526277
... We work closely with the FDA and other drug agencies, like EMA [European Medicines Agency] and PDMA [Pharmaceuticals and Medical Devices Agency], to look at endpoints for drug trials, or how to improve drug trials to benefit sponsors and patients.	Rein > Maladies rénales	Partenariat réglementaire > Travailler avec les organismes de réglementation	100 000	National	Regularly	119070696943
Participation in activities like PDUFA [Prescription Drug User Fee Act] and MDUFA [Medical Device User Fee and Modernization Act] discussions.	Rare > Maladies rares : la plupart des types	Partenariat réglementaire > Travailler avec les organismes de réglementation	100 000	National	Rarely	119078556821
We have a policy committee and weigh in on public policy issues through education and advocacy.	Chronique > Palliatif	Partenariat réglementaire > Travailler avec les organismes de réglementation	100	National	Regularly	119078649119
Discussions about review and approvals of new screening technologies.	Cancer > Cancer : la plupart des types	Partenariat réglementaire > Participer aux évaluations des technologies de santé (ETS) et aux examens de remboursement	100 000	National	Rarely	119045117950
Our organisation actively advocates for the interests of the individuals and communities we serve before regulatory authorities and decision-making bodies on matters relating to medicine access, affordability, and coverage recommendations.	Défense des droits des patients > Formation	Partenariat réglementaire > Participer aux évaluations des technologies de santé (ETS) et aux examens de remboursement	100 000	International	Regularly	119063146174
... Our government relations team responds to comment letters and regularly talks with CMS [Centers for Medicare & Medicaid Services] to ensure best outcomes.	Rein > Maladies rénales	Partenariat réglementaire > Participer aux évaluations des technologies de santé (ETS) et aux examens de remboursement	100 000	National	Regularly	119070696943
Our organization has participated in responses to ICER [Institute for Clinical and Economic Review].	Respiratoire > Maladies pulmonaires	Partenariat réglementaire > Participer aux évaluations des technologies de santé (ETS) et aux examens de remboursement	100 000	International	Rarely	119078556838
We are typically advisors on ICER [Institute for Clinical and Economic Review] reviews.	Rhumatismal > Lupus	Partenariat réglementaire > Participer aux évaluations des technologies de santé (ETS) et aux examens de remboursement	100 000	National	Regularly	119082751826
Testifying on behalf of pharma & device companies in front of the FDA [Food and Drug Administration].	Transplantations > Transplantations : cœur et poumon	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	5 000	Local	Regularly	119014633092
Discussions with FDA [Food and Drug Administration].	Santé générale > Communautés diverses	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	10 000	International	Rarely	119026771169
I personally have testified before the FDA [Food and Drug Administration] and CMS [Centers for Medicare & Medicaid Services].	Transplantations > Transplantations : cœur et poumon	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	1 000	Regional	Sometimes	119037216727
We collaborated on an externally-led Patient-Focused Drug Development meeting with the FDA [Food and Drug Administration] in 2025.	Neurologique > Sclérose en plaques	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	100 000	National	Rarely	119039458452
Meeting with people at CMS [Centers for Medicare & Medicaid Services] to weigh in on drug pricing negotiation potential consequences.	Rare > Maladies rares : la plupart des types	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	5 000	National	Sometimes	119046591776
Elevating the patient voice and sharing insights from our patient experience registry at meetings such as ODAC [Oncologic Drugs Advisory Committee] and MDPNP [Medical Device Patient Network Program] listening sessions.	Cancer > Cancer : autre	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	100 000	International	Regularly	119047535935
Communications with FDA [Food and Drug Administration], participating in public comment sessions.	Sang > Anémie	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	5 000	National	Regularly	119050770645
We work with FDA [Food and Drug Administration], Congress, and the White House on federal policies that affect liver patients.	Foie > Maladies du foie : la plupart des types	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	100 000	International	Regularly	119054948119
Testifying at ODAC [Oncologic Drugs Advisory Committee].	Cancer > Cancer : autre	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	100 000	International	Sometimes	119059387919
Just recently hosted an EL-PFDD [Externally-Led Patient-Focused Drug Development] meeting and attended FDA [Food and Drug Administration] meetings with industry partners.	Rare > Maladies rares : génétiques	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	5 000	International	Regularly	119065526277
EL-PFDD [Externally-Led Patient-Focused Drug Development] FDA [Food and Drug Administration] Patient Listening Sessions.	Défense des droits des patients > Militant pour la santé	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	10 000	National	Regularly	119066130575
We have testified at FDA [Food and Drug Administration] Adcomms [Advisory Committees] and have helped organise Patient-Focused Drug Development meetings.	Neuromusculaire > Maladies neuromusculaires : la plupart des types	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	100 000	National	Sometimes	119068005400
Actively participate in Patient Focused Drug Development with FDA [Food and Drug Administration].	Rhumatismal > Lupus	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	100 000	National	Regularly	119070039917
We have held multiple externally led patient-focused drug development (EL-PFDD [Externally Led Patient-Focused Drug Development]) meetings with the FDA [Food and Drug Administration]. We invite regulators to all our scientific workshops. We educate patients and facilitate meetings with regulators on an ongoing basis.	Rein > Maladies rénales	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	100 000	National	Regularly	119070696943
We provide public comment on new drugs to the FDA [Food and Drug Administration].	Sang > Drépanocytose	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	10 000	Regional	Sometimes	119074242460
Participation in activities like PDUFA [Prescription Drug User Fee Act] and MDUFA [Medical Device User Fee and Modernization Act] discussions.	Rare > Maladies rares : la plupart des types	Partenariat réglementaire > Assister/faciliter des réunions avec des décideurs politiques/régulateurs	100 000	National	Rarely	119078556821
Coalition work.	Rare > Maladies rares : droits des patients	Partenariat réglementaire > Avec d'autres défenseurs des soins de santé	100 000	National	Sometimes	119050874740
We lead the national coalition EACH [Ensuring Access through Collaborative Health]/PIC [Patient Inclusion Council] coalition, working on government drug affordability reviews.	Auto-immune > Auto-immune : autre	Partenariat réglementaire > Avec d'autres défenseurs des soins de santé	100 000	International	Regularly	119071535440
In Arizona and, on occasion, more broadly across the USA, we collaborate with other cancer groups, organisations, and legislators.	Cancer > Cancer : sang	Partenariat réglementaire > Avec d'autres défenseurs des soins de santé	Do not know	Regional	Sometimes	119078394447
Lobbying on the state and federal level on rules/laws that impact our patients.	Santé générale > Prestation de soins de santé	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	100	National	Sometimes	119011450240
Our Cancer Policy Institute advocates for equitable access to medicines to government organizations such as CMS [Centers for Medicare & Medicaid Services].	Cancer > Cancer : autre	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	100 000	International	Regularly	119020437168
We include a discussion of medication pricing in our conversations with the state and federal government employees. We are also pushing for lifetime coverage of physical therapy for people with PD [Parkinson's Disease], as maintaining balance as the disease progresses saves both providers and insurers money in the long run.	Neurodégénératif > Parkinson	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	100 000	Regional	Rarely	119020536956
Advocacy with PBM [Pharmacy Benefit Manager], Medicare and state legislatures.	Rhumatismal > Lupus	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	5 000	Regional	Sometimes	119037794627
Advocacy with PBM [Pharmacy Benefit Manager], Medicare and state legislatures.	Rhumatismal > Lupus	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	5 000	Regional	Sometimes	119037794627
...The organization's flagship event - the annual Indo US Bridging RARE Summit brings together rare disease stakeholders, including scientists, patient advocates, government officials, biopharma executives, and policy experts who share a common goal: transforming the future of care for the 400 million people worldwide living with rare diseases.	Rare > Maladies rares : la plupart des types	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	100	International	Regularly	119038170136
Invitation to the White House in 2024 to discuss cancer research funding with the First Lady's office.	Cancer > Cancer : recherche médicale	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	1 000	National	Rarely	119044810653
We work with FDA [Food and Drug Administration], Congress, and the White House on federal policies that affect liver patients.	Foie > Maladies du foie : la plupart des types	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	100 000	International	Regularly	119054948119
We frequently engage on state and federal issues related to patient access to care.	Respiratoire > Maladies pulmonaires	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	100 000	National	Rarely	119055217525
We regularly advocate through sign-on letters, policymaker discussions, and policy related programming.	Cancer > Cancer : communautés diverses	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	5 000	National	Sometimes	119055664199
We both authored and signed on to letters to state and federal (private insurance and CMS [Centers for Medicare & Medicaid Services]) on a variety of issues.	Cardiovasculaire > Maladies cardiovasculaires et cardiaques	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	Over 100,000	International	Sometimes	119058234393
Campaigning with KidneyCAN for increased federal research funding.	Cancer > Cancer : rein	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	1 000	Regional	Sometimes	119059282158
The Community Liver Alliance represents patient interests to regulators and policymakers responsible for advising on and determining drug pricing. We engage at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. Our advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases. We elevate patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies.	Foie > Maladies du foie : la plupart des types	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	100 000	National	Regularly	119059491202
We communicate with federal representatives about the importance of funding.	Cancer > Cancer : cerveau	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	We do not communicate with patients directly	National	Sometimes	119061001133
We bring patient perspectives opposing use of QALYs [Quality-Adjusted Life Years].	Défense des droits des patients > Militant pour la santé	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	Do not know	National	Regularly	119065430409
Just one example: we continually advocate (both through regulatory comments and now legislation) for adequate reimbursement for new and innovative drugs in the ESRD [End-Stage Renal Disease] space through TDAPA [Transitional Drug Add-on Payment Adjustment] and a sustainable post-TDAPA payment pathway.	Rein > Maladies rénales	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	Over 100,000	National	Regularly	119068073151
We work with state, federal policymakers and health insurers.	Santé générale > Obésité	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	Over 100,000	National	Sometimes	119068989651
As a transgender-led healthcare organization, ETSI [Ending Transmission of Sexual Infections] also brings the perspective of historically marginalized communities into healthcare discussions. The clinic advocates for policies that protect medication affordability, expand HIV prevention services, and strengthen programs that reduce the cost of prescription drugs for safety-net providers. Through patient care, community engagement, and participation in public health programs, ETSI Health Clinic ensures that the voices and needs of vulnerable patients are represented in conversations about medication access and healthcare equity.	VIH > VIH et santé sexuelle	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	100	Regional	Regularly	119073874628
Supported efforts to have an ICD-10 (International Classification of Diseases, 10th Revision) code for VEXAS syndrome.	Rare > Maladies auto-inflammatoires	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	1 000	International	Sometimes	119074154009
We provide public comment on new drugs to the FDA. We regularly organize delegations to Capitol Hill to advocate for Medicaid and Medicare support for sickle cell treatment. We advocate with New Jersey legislators for support for sickle cell treatment and services.	Sang > Drépanocytose	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	10 000	Regional	Sometimes	119074242460
Testifying at PDAB meetings [submitting comments to a Patient Drug Affordability Board during a public meeting, hearing, or review process] writing letters to decision-makers at state and federal level [USA].	Rare > Mucoviscidose	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	10 000	National	Sometimes	119078388026
In Arizona and occasionally, the U.S., we collaborate with other cancer groups, organizations, and legislators who support legislation that will help cancer research, the medical/oncology groups, and cancer patients and families.	Cancer > Cancer : sang	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	Do not know	Regional	Sometimes	119078394447
We have a policy committee and weigh in on public policy issues through education and advocacy.	Chronique > Palliatif	Influencer les politiques et la législation > Influencer les politiques et la législation en matière de santé	100	National	Regularly	119078649119
We include a discussion of medication pricing in our discussions with state and federal government employees.	Neurodégénératif > Parkinson	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	100 000	Regional	Rarely	119020536956
We submitted comments to CMS [Centers for Medicare & Medicaid Services] regarding the price negotiation of mental health and neurological conditions.	Santé mentale > Santé mentale : stigmatisation	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	We do not communicate with patients directly	National	Sometimes	119024698241
IndoUSrare participates in RDLA's [Rare Disease Legislative Advocates] Rare Disease Week on Capitol Hill and advocates to legislators on behalf of our patient alliance members and the rare disease community.	Rare > Maladies rares : la plupart des types	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	100	International	Regularly	119038170136
Testify before prescription drug affordability boards.	Saignement > Troubles hémorragiques : la plupart des types	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	1 000	Local	Regularly	119044404340
Communications with FDA [Food and Drug Administration], participating in public comment sessions.	Sang > Anémie	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	5 000	National	Regularly	119050770645
We regularly advocate through sign-on letters, policymaker discussions, and policy related programming.	Cancer > Cancer : communautés diverses	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	5 000	National	Sometimes	119055664199
We both authored and signed on to letters to state and federal (private insurance and CMS [Centers for Medicare & Medicaid Services]) on a variety of issues.	Cardiovasculaire > Maladies cardiovasculaires et cardiaques	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	Over 100,000	International	Sometimes	119058234393
... Testifying at IRA [Inflation Reduction Act] listening sessions to elevate the patient experience.	Cancer > Cancer : autre	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	100 000	International	Sometimes	119059387919
The Community Liver Alliance engages at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. The Community Liver Alliance's advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases.	Foie > Maladies du foie : la plupart des types	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	100 000	National	Regularly	119059491202
Through written comments, sign-on letters, and participating in roundtable meetings where drugs are being discussed.	Cancer > Cancer : sarcome	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	10 000	International	Sometimes	119064713792
We work with the state agencies that oversee our Medicaid program, our exchange and private insurance. We hold quarterly meetings with them to discuss patient access issues. We also provide letters and testimony to the board that oversees health care costs in our state.	Saignement > Troubles hémorragiques : la plupart des types	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	5 000	Regional	Regularly	119069774462
... Our government relations team responds to comment letters and regularly talks with CMS [Centers for Medicare & Medicaid Services] to ensure best outcomes.	Rein > Maladies rénales	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	100 000	National	Regularly	119070696943
We provided comments to federal and state regulators around drug pricing in the 340B program [in the US, these reforms seek to overhaul the 1992 federal program that mandates pharmaceutical manufacturers provide steep drug discounts to safety-net hospitals and clinics] when asking for community input to proposed policy changes.	Éducation du patient > Informations sur le patient	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	5 000	National	Sometimes	119073380443
We are not a lobbying organization, we are a 501 c-3 non-profit public charity. We sign on to letters with partner societies who are lobbying for better access to care. We host roundtables and advocacy awareness days with legislators where we raise awareness of current problems and offer solutions. One recent event was with the Governor of Virginia. We are planning a Spine Health Fair at the US Capitol in September.	Santé générale > Mode de vie	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	100 000	National	Sometimes	119074217249
We provide public comment on new drugs to the FDA [Food and Drug Administration].	Sang > Drépanocytose	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	10 000	Regional	Sometimes	119074242460
Work with NYSTAG [New York State Technical Advisory Group-generally refers to ad-hoc or specialised panels of industry experts, academics, and stakeholders assembled by NY state agencies to advise on specific policies, healthcare, or emerging technologies.].	Santé générale > Prestation de soins de santé	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	5 000	Regional	Sometimes	119078326039
Testifying at PDAB meetings [submitting comments to a Patient Drug Affordability Board during a public meeting, hearing, or review process] writing letters to decision-makers at state and federal level [USA].	Rare > Mucoviscidose	Influencer les politiques et la législation > Participer aux audiences publiques et aux consultations	10 000	National	Sometimes	119078388026
IndoUSrare participates in RDLA's [Rare Disease Legislative Advocates] Rare Disease Week on Capitol Hill and advocates to legislators on behalf of our patient alliance members and the rare disease community.	Rare > Maladies rares : la plupart des types	Influencer les politiques et la législation > Mobiliser les parlementaires et les dirigeants politiques	100	International	Regularly	119038170136
Invitation to the White House in 2024 to discuss cancer research funding with the First Lady's office.	Cancer > Cancer : recherche médicale	Influencer les politiques et la législation > Mobiliser les parlementaires et les dirigeants politiques	1 000	National	Rarely	119044810653
We communicate with federal representatives about the importance of funding.	Cancer > Cancer : cerveau	Influencer les politiques et la législation > Mobiliser les parlementaires et les dirigeants politiques	We do not communicate with patients directly	National	Sometimes	119061001133
We provide public comment on new drugs to the FDA. We regularly organize delegations to Capitol Hill to advocate for Medicaid and Medicare support for sickle cell treatment. We advocate with New Jersey legislators for support for sickle cell treatment and services.	Sang > Drépanocytose	Influencer les politiques et la législation > Mobiliser les parlementaires et les dirigeants politiques	10 000	Regional	Sometimes	119074242460
... We are active in Lupus Caucus [Congressional Lupus Caucus, a bipartisan group of lawmakers focused on raising awareness about lupus and securing federal funding for research and education]	Rhumatismal > Lupus	Influencer les politiques et la législation > Mobiliser les parlementaires et les dirigeants politiques	100 000	National	Regularly	119082751826
Government Relations/Advocacy team signs letters in support of lower drug prices.	Cancer > Cancer : prostate	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	100 000	National	Sometimes	119011723588
We include a discussion of medication pricing in our discussions with state and federal government employees.	Neurodégénératif > Parkinson	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	100 000	Regional	Rarely	119020536956
Testify before prescription drug affordability boards.	Saignement > Troubles hémorragiques : la plupart des types	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	1 000	Local	Regularly	119044404340
Drug assistance programs and co-pay assistance foundation.	Cancer > Cancer : la plupart des types	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	5 000	International	Sometimes	119045428228
We frequently engage on state and federal issues related to patient access to care, occasionally weighing in on issues adjacent to drug pricing, though it is not our primary focus.	Respiratoire > Maladies pulmonaires	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	100 000	National	Rarely	119055217525
The Community Liver Alliance represents patient interests to regulators and policymakers responsible for advising on and determining drug pricing. We engage at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. Our advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases. We elevate patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies	Foie > Maladies du foie : la plupart des types	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	100 000	National	Regularly	119059491202
Promoting 340B reforms [in the US, these reforms seek to overhaul the 1992 federal program that mandates pharmaceutical manufacturers provide steep drug discounts to safety-net hospitals and clinics].	Défense des droits des patients > Militant pour la santé	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	10 000	Regional	Regularly	119059636045
Have written support letters from the "patient voice" as part of our advocacy efforts related to drug pricing.	Cancer > Cancer : cerveau	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	1 000	National	Rarely	119061176158
Our organisation actively advocates for the interests of the individuals and communities we serve before regulatory authorities and decision-making bodies on matters relating to medicine access, affordability, and coverage recommendations.	Défense des droits des patients > Formation	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	100 000	International	Regularly	119063146174
We bring patient perspectives opposing use of QUALYs [quality-adjusted life years] and opposing importing drug prices from other countries [oustide of the USA], especially those that use QALYs.	Défense des droits des patients > Militant pour la santé	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	Do not know	National	Regularly	119065430409
Just one example: we continually advocate (both through regulatory comments and now legislation) for adequate reimbursement for new and innovative drugs in the ESRD [End-Stage Renal Disease] space through TDAPA [Transitional Drug Add-on Payment Adjustment] and a sustainable post-TDAPA payment pathway.	Rein > Maladies rénales	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	Over 100,000	National	Regularly	119068073151
We work with the state agencies that oversee our Medicaid program, our exchange and private insurance. We hold quarterly meetings with them to discuss patient access issues. We also provide letters and testimony to the board that oversees health care costs in our state.	Saignement > Troubles hémorragiques : la plupart des types	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	5 000	Regional	Regularly	119069774462
ETSI [Ending Transmission of Sexual Infections] Health Clinic represents the interests of patients—particularly those impacted by HIV, LGBTQ+ individuals, and underserved communities—by advocating for affordable access to life-saving medications.	VIH > VIH et santé sexuelle	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	100	Regional	Regularly	119073874628
Pharma pricing.	Santé générale > Obésité	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	100 000	National	Regularly	119076659022
With our new Public Policy department, this may come up as an opportunity to advocate for drug pricing.	Neurodégénératif > Parkinson	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	100 000	National	Sometimes	119078318937
Cost for SCD [Sickle Cell Disease] treatments as they came to market during the last 7 years.	Sang > Drépanocytose	Plaidoyer pour la tarification et l'accessibilité financière > Plaider pour une tarification équitable des médicaments	5 000	National	Sometimes	119079213376
We have participated in the IRA [Inflation Reduction Act] price negotiation round tables.	Respiratoire > Asthme et allergie	Plaidoyer pour la tarification et l'accessibilité financière > Participer aux négociations du comité d'examen des prix	100 000	National	Regularly	119011501209
We have participated in the IRA [Inflation Reduction Act of 2022] price negotiation round tables [The IRA provides Medicare (the US federal health insurance program for people age 65 and older) powers to negotiate lower prescription costs].	Respiratoire > Asthme et allergie	Plaidoyer pour la tarification et l'accessibilité financière > Participer aux négociations du comité d'examen des prix	100 000	National	Regularly	119011501209
We submitted comments to CMS [Centers for Medicare & Medicaid Services] regarding the price negotiation of mental health and neurological conditions.	Santé mentale > Santé mentale : stigmatisation	Plaidoyer pour la tarification et l'accessibilité financière > Participer aux négociations du comité d'examen des prix	We do not communicate with patients directly	National	Sometimes	119024698241
... meetings with state office of CMS [Centers for Medicare & Medicaid Services].	Saignement > Troubles hémorragiques : la plupart des types	Plaidoyer pour la tarification et l'accessibilité financière > Participer aux négociations du comité d'examen des prix	1 000	Local	Regularly	119044404340
Meeting with people at CMS [Centers for Medicare & Medicaid Services] to weigh in on drug pricing negotiation potential consequences.	Rare > Maladies rares : la plupart des types	Plaidoyer pour la tarification et l'accessibilité financière > Participer aux négociations du comité d'examen des prix	5 000	National	Sometimes	119046591776
We educate advocates on outreach to Patient Drug Affordability Boards [Patient Drug Affordability Boards are state government boards that review prescription drug prices and, in some US states, can take actions to help make drugs more affordable.]	Cancer > Cancer : communautés diverses	Plaidoyer pour la tarification et l'accessibilité financière > Participer aux négociations du comité d'examen des prix	100 000	National	Sometimes	119054172981
The Community Liver Alliance's advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases.	Foie > Maladies du foie : la plupart des types	Plaidoyer pour la tarification et l'accessibilité financière > Participer aux négociations du comité d'examen des prix	100 000	National	Regularly	119059491202
PDABs [Prescription Drug Affordability Boards]; IRA [Inflation Reduction Act]; Medicaid P&T [Pharmacy and Therapeutics] committees.	Défense des droits des patients > Militant pour la santé	Plaidoyer pour la tarification et l'accessibilité financière > Participer aux négociations du comité d'examen des prix	We do not communicate with patients directly	National	Regularly	119064160791
We participated in the Medicare price negotiation roundtables and town hall last year.	Respiratoire > Asthme et allergie	Plaidoyer pour la tarification et l'accessibilité financière > Participer aux négociations du comité d'examen des prix	100 000	National	Regularly	119069847466
Actively participate in patient-focused drug development with the FDA [Food and Drug Administration] and CMS [Centers for Medicare & Medicaid Services]/HHS [U.S. Department of Health and Human Services] Prescription Access discussions.	Rhumatismal > Lupus	Plaidoyer pour la tarification et l'accessibilité financière > Participer aux négociations du comité d'examen des prix	100 000	National	Regularly	119070039917
We lead the national coalition EACH [Ensuring Access through Collaborative Health]/PIC [Patient Inclusion Council] coalition, working on government drug affordability reviews.	Auto-immune > Auto-immune : autre	Plaidoyer pour la tarification et l'accessibilité financière > Participer aux négociations du comité d'examen des prix	100 000	International	Regularly	119071535440
We provided comments to federal and state regulators around drug pricing in the 340B program [in the US, these reforms seek to overhaul the 1992 federal program that mandates pharmaceutical manufacturers provide steep drug discounts to safety-net hospitals and clinics] when asking for community input to proposed policy changes.	Éducation du patient > Informations sur le patient	Plaidoyer pour la tarification et l'accessibilité financière > Participer aux négociations du comité d'examen des prix	5 000	National	Sometimes	119073380443
We communicate to them that many HD [Huntington's disease] families are low income as often the one making the money is the one with HD. So cost of meds can impact whether they can afford the meds.	Neurodégénératif > Maladie de Huntington	Plaidoyer pour la tarification et l'accessibilité financière > Réduire les obstacles financiers pour les personnes à faibles revenus et les personnes vulnérables	100 000	National	Sometimes	119017688949
Health insurance companies and health insurance reps organize activities for low income communities.	Personnes âgées > Personnes âgées	Plaidoyer pour la tarification et l'accessibilité financière > Réduire les obstacles financiers pour les personnes à faibles revenus et les personnes vulnérables	Over 100,000	International	Sometimes	119035935608
ETSI [Ending Transmission of Sexual Infections] Health Clinic represents the interests of patients—particularly those impacted by HIV, LGBTQ+ individuals, and underserved communities—by advocating for affordable access to life-saving medications and healthcare services. Through its participation in programs such as the 340B Drug Pricing Program [in the US, these reforms seek to overhaul the 1992 federal program that mandates pharmaceutical manufacturers provide steep drug discounts to safety-net hospitals and clinics], ETSI works to ensure that low-income and uninsured patients have access to reduced-cost prescription medications, including HIV treatment and prevention medications like PrEP.	VIH > VIH et santé sexuelle	Plaidoyer pour la tarification et l'accessibilité financière > Réduire les obstacles financiers pour les personnes à faibles revenus et les personnes vulnérables	100	Regional	Regularly	119073874628
We regularly provide comments to state P&T [Pharmacy and Therapeutics] committees regarding their formulary inclusions and exclusions.	Respiratoire > Asthme et allergie	Plaidoyer pour la tarification et l'accessibilité financière > Plaidoyer pour l'inclusion du produit dans les listes de remboursement/formulaires nationaux	100 000	National	Regularly	119011501209
PDABs [Prescription Drug Affordability Boards]; IRA [Inflation Reduction Act]; Medicaid P&T [Pharmacy and Therapeutics] committees.	Défense des droits des patients > Militant pour la santé	Plaidoyer pour la tarification et l'accessibilité financière > Plaidoyer pour l'inclusion du produit dans les listes de remboursement/formulaires nationaux	We do not communicate with patients directly	National	Regularly	119064160791
Invitation to the White House in 2024 to discuss cancer research funding with First Lady's office. Lastly, I've co-written op-eds and on the local level recorded a video (ACS) targeting NYS lawmakers and the advocacy for increased equity and access to biomarker testing for patients.	Cancer > Cancer : recherche médicale	Plaidoyer pour la tarification et l'accessibilité financière > Participer à des campagnes de sensibilisation	1 000	National	Rarely	119044810653
Advocacy in access to care issues.	Cancer > Cancer : la plupart des types	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	10 000	Regional	Sometimes	119011457943
Our Cancer Policy Institute advocates for equitable access to medicines to government organizations such as CMS [Centers for Medicare & Medicaid Services].	Cancer > Cancer : autre	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	100 000	International	Regularly	119020437168
We include a discussion of medication pricing in our conversations with the state and federal government employees. We are also pushing for lifetime coverage of physical therapy for people with PD [Parkinson's Disease], as maintaining balance as the disease progresses saves both providers and insurers money in the long run.	Neurodégénératif > Parkinson	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	100 000	Regional	Rarely	119020536956
... We sent letters to States to request that they change their step requirements for access to mental health treatments.	Santé mentale > Santé mentale : stigmatisation	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	We do not communicate with patients directly	National	Sometimes	119024698241
Invitation to the White House in 2024 to discuss cancer research funding with First Lady's office. Lastly, I've co-written op-eds and on the local level recorded a video (ACS) targeting NYS lawmakers and the advocacy for increased equity and access to biomarker testing for patients.	Cancer > Cancer : recherche médicale	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	1 000	National	Rarely	119044810653
Drug assistance programs and co-pay assistance foundation.	Cancer > Cancer : la plupart des types	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	5 000	International	Sometimes	119045428228
We frequently engage on state and federal issues related to patient access to care.	Respiratoire > Maladies pulmonaires	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	100 000	National	Rarely	119055217525
The Community Liver Alliance elevates patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies.	Foie > Maladies du foie : la plupart des types	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	100 000	National	Regularly	119059491202
We might provide patient stories and testimonials when needed to ensure importance of continued access to a particular drug.	Neurologique > Migraine/autres troubles des céphalées	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	100 000	National	Rarely	119060019780
Our organisation actively advocates for the interests of the individuals and communities we serve before regulatory authorities and decision-making bodies on matters relating to medicine access, affordability, and coverage recommendations.	Défense des droits des patients > Formation	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	100 000	International	Regularly	119063146174
State level Medicaid.	Cancer > Cancer : la plupart des types	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	1 000	National	Rarely	119068136322
We work with the state agencies that oversee our Medicaid program, our exchange and private insurance. We hold quarterly meetings with them to discuss patient access issues. We also provide letters and testimony to the board that oversees health care costs in our state.	Saignement > Troubles hémorragiques : la plupart des types	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	5 000	Regional	Regularly	119069774462
We are currently addressing access to biologic medications.	Rare > Maladies rares : immunitaires	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	10 000	National	Sometimes	119069849386
Actively participate in patient-focused drug development with the FDA [Food and Drug Administration] and CMS [Centers for Medicare & Medicaid Services]/HHS [U.S. Department of Health and Human Services] Prescription Access discussions.	Rhumatismal > Lupus	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	100 000	National	Regularly	119070039917
We are not a lobbying organization, we are a 501 c-3 non-profit public charity. We sign on to letters with partner societies who are lobbying for better access to care. Support with formal cost-approval (reimbursement authorisation) applications and with newly introduced restrictions on treatment options.	Santé générale > Mode de vie	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	100 000	National	Sometimes	119074217249
Pharma pricing, coverage, indications.	Santé générale > Obésité	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	100 000	National	Regularly	119076659022
We have on only a few occasions advocated for better access to newer drugs.	Santé mentale > Santé mentale : stigmatisation	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	Over 100,000	International	Rarely	119078209025
Cost for SCD [Sickle Cell Disease] treatments as they came to market during the last 7 years.	Sang > Drépanocytose	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	5 000	National	Sometimes	119079213376
... convene MAPRx [Medicare Access for Patients Rx] for Medicare Part D, etc.[MAPRx is guided by the idea that every Medicare Part D beneficiary should have timely, affordable access to the medications they need to live a healthy life.]	Rhumatismal > Lupus	Amélioration des voies d'accès > Faciliter l'accès équitable aux médicaments/soins de santé	100 000	National	Regularly	119082751826
... We sent letters to States to request that they change their step requirements for access to mental health treatments.	Santé mentale > Santé mentale : stigmatisation	Amélioration des voies d'accès > Remédier aux disparités en matière d'accès et de gestion	We do not communicate with patients directly	National	Sometimes	119024698241
We work with the state agencies that oversee our Medicaid program, our exchange and private insurance. We hold quarterly meetings with them to discuss patient access issues. We also provide letters and testimony to the board that oversees health care costs in our state.	Saignement > Troubles hémorragiques : la plupart des types	Amélioration des voies d'accès > Remédier aux disparités en matière d'accès et de gestion	5 000	Regional	Regularly	119069774462
IndoUSrare participates in RDLA's [Rare Disease Legislative Advocates] Rare Disease Week on Capitol Hill and advocates to legislators on behalf of our patient alliance members and the rare disease community.	Rare > Maladies rares : la plupart des types	Amélioration des voies d'accès > Améliorer l'accès aux thérapies rares/ultra-rares	100	International	Regularly	119038170136
Elevating the patient voice and sharing insights from our patient experience registry at meetings such as ODAC [Oncologic Drugs Advisory Committee] and MDPNP [Medical Device Patient Network Program] listening sessions.	Cancer > Cancer : autre	Contribution des patients fondée sur des données probantes > Utilisez les informations sur les patients pour éclairer les décisions	100 000	International	Regularly	119047535935
Elevating the patient voice and sharing insights from our patient experience registry at meetings such as ODAC [Oncologic Drugs Advisory Committee] and MDPNP [Medical Device Patient Network Program] listening sessions.	Cancer > Cancer : autre	Contribution des patients fondée sur des données probantes > Utilisez les informations sur les patients pour éclairer les décisions	100 000	International	Regularly	119047535935
Held an EL-PFDD [Externally-Led Patient-Focused Drug Development] meeting.	Neurodégénératif > Démence	Contribution des patients fondée sur des données probantes > Utilisez les informations sur les patients pour éclairer les décisions	Do not know	National	Sometimes	119052219350
Serve on the Alliance for Breast Cancer Policy [The Alliance for Breast Cancer Policy is a coalition of over 25 national patient advocacy organizations founded by Susan G. Komen. The network unites advocates, community members, and industry partners to drive federal policy changes that improve access to care, eliminate out-of-pocket costs, and improve outcomes]. We were just part of a manuscript written for the launch of the global Breast Cancer Care Quality Index: https://www.mdpi.com/1660-4601/23/2/207	Cancer > Cancer : sein	Contribution des patients fondée sur des données probantes > Utilisez les informations sur les patients pour éclairer les décisions	100 000	International	Sometimes	119052475951
We bring patient perspectives opposing use of QALYs [Quality-Adjusted Life Years].	Défense des droits des patients > Militant pour la santé	Contribution des patients fondée sur des données probantes > Utilisez les informations sur les patients pour éclairer les décisions	Do not know	National	Regularly	119065430409
Actively participate in Patient Focused Drug Development with FDA [Food and Drug Administration].	Rhumatismal > Lupus	Contribution des patients fondée sur des données probantes > Utilisez les informations sur les patients pour éclairer les décisions	100 000	National	Regularly	119070039917
We have held multiple externally led patient-focused drug development (EL-PFDD [Externally Led Patient-Focused Drug Development]) meetings with the FDA [Food and Drug Administration].	Rein > Maladies rénales	Contribution des patients fondée sur des données probantes > Utilisez les informations sur les patients pour éclairer les décisions	100 000	National	Regularly	119070696943
As a transgender-led healthcare organization, ETSI [Ending Transmission of Sexual Infections] also brings the perspective of historically marginalized communities into healthcare discussions. The clinic advocates for policies that protect medication affordability, expand HIV prevention services, and strengthen programs that reduce the cost of prescription drugs for safety-net providers. Through patient care, community engagement, and participation in public health programs, ETSI Health Clinic ensures that the voices and needs of vulnerable patients are represented in conversations about medication access and healthcare equity.	VIH > VIH et santé sexuelle	Contribution des patients fondée sur des données probantes > Utilisez les informations sur les patients pour éclairer les décisions	100	Regional	Regularly	119073874628
We provide data and real-world knowledge.	Foie > Maladies du foie : la plupart des types	Contribution des patients fondée sur des données probantes > Fournir des preuves du monde réel (RWE) aux agences réglementaires	100 000	National	Sometimes	119045306046
The Community Liver Alliance represents patient interests to regulators and policymakers responsible for advising on and determining drug pricing. We engage at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. Our advocacy includes engagement with CMS [Centers for Medicare & Medicaid Services], participation in public comment opportunities (including those related to Medicare Drug Price Negotiation), collaboration with policymakers on PBM [Pharmacy Benefit Manager] reform, and education of regulatory stakeholders about the real-world impact of pricing decisions on patients with chronic and rare liver diseases. We elevate patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies	Foie > Maladies du foie : la plupart des types	Contribution des patients fondée sur des données probantes > Fournir des preuves du monde réel (RWE) aux agences réglementaires	100 000	National	Regularly	119059491202
ETSI [Ending Transmission of Sexual Infections] Health Clinic collaborates with pharmacy partners and public health systems to highlight the real-world impact that medication costs have on patients living with HIV and those at risk. By documenting patient barriers to medication access, the clinic helps inform healthcare partners and policymakers about the financial and systemic challenges patients face.	VIH > VIH et santé sexuelle	Contribution des patients fondée sur des données probantes > Fournir des preuves du monde réel (RWE) aux agences réglementaires	100	Regional	Regularly	119073874628
We communicate to them that many HD [Huntington's Disease] families are low income, as often the one making the money is the one with HD.	Neurodégénératif > Maladie de Huntington	Contribution des patients fondée sur des données probantes > Exploiter les témoignages de patients et les récits d'expériences vécues	100 000	National	Sometimes	119017688949
The Community Liver Alliance engages at the federal and state levels to ensure that the lived experiences of people affected by liver disease inform policy decisions related to drug access, affordability, and reimbursement. We elevate patient and caregiver voices to ensure pricing policies balance innovation with equitable and timely access to life-saving therapies.	Foie > Maladies du foie : la plupart des types	Contribution des patients fondée sur des données probantes > Exploiter les témoignages de patients et les récits d'expériences vécues	100 000	National	Regularly	119059491202
We might provide patient stories and testimonials when needed to ensure importance of continued access to a particular drug.	Neurologique > Migraine/autres troubles des céphalées	Contribution des patients fondée sur des données probantes > Exploiter les témoignages de patients et les récits d'expériences vécues	100 000	National	Rarely	119060019780
Have written support letters from the "patient voice" as part of our advocacy efforts related to drug pricing.	Cancer > Cancer : cerveau	Contribution des patients fondée sur des données probantes > Exploiter les témoignages de patients et les récits d'expériences vécues	1 000	National	Rarely	119061176158
Held an EL-PFDD [Externally-Led Patient-Focused Drug Development] meeting.	Neurodégénératif > Démence	Contribution des patients fondée sur des données probantes > Mener des enquêtes/recherches pour générer des données	Do not know	National	Sometimes	119052219350
Serve on the Alliance for Breast Cancer Policy [The Alliance for Breast Cancer Policy is a coalition of over 25 national patient advocacy organizations founded by Susan G. Komen. The network unites advocates, community members, and industry partners to drive federal policy changes that improve access to care, eliminate out-of-pocket costs, and improve outcomes]. We were just part of a manuscript written for the launch of the global Breast Cancer Care Quality Index: https://www.mdpi.com/1660-4601/23/2/207	Cancer > Cancer : sein	Contribution des patients fondée sur des données probantes > Mener des enquêtes/recherches pour générer des données	100 000	International	Sometimes	119052475951
As a transgender-led healthcare organization, ETSI [Ending Transmission of Sexual Infections] also brings the perspective of historically marginalized communities into healthcare discussions. The clinic advocates for policies that protect medication affordability, expand HIV prevention services, and strengthen programs that reduce the cost of prescription drugs for safety-net providers. Through patient care, community engagement, and participation in public health programs, ETSI Health Clinic ensures that the voices and needs of vulnerable patients are represented in conversations about medication access and healthcare equity.	VIH > VIH et santé sexuelle	Contribution des patients fondée sur des données probantes > Traduire les preuves et les informations en contributions politiques	100	Regional	Regularly	119073874628
... We work closely with the FDA and other drug agencies, like EMA [European Medicines Agency] and PDMA [Pharmaceuticals and Medical Devices Agency], to look at endpoints for drug trials, or how to improve drug trials to benefit sponsors and patients.	Rein > Maladies rénales	Diagnostic et livraison de médicaments > Collaborer sur la conception d'essais cliniques	100 000	National	Regularly	119070696943
Supporting legislation for multiple cancer early detection, including TV appearances and social media.	Cancer > Cancer : aidants, famille, amis	Diagnostic et livraison de médicaments > Soutenir le dépistage et la détection précoce	1 000	Regional	Regularly	119036085844
Discussions about review and approvals of new screening technologies.	Cancer > Cancer : la plupart des types	Diagnostic et livraison de médicaments > Soutenir le dépistage et la détection précoce	100 000	National	Rarely	119045117950
USPTF [U.S. Preventive Services Task Force] input.	Cancer > Cancer : hommes	Diagnostic et livraison de médicaments > Soutenir le dépistage et la détection précoce	100 000	National	Sometimes	119050776275
Sit on several panels.	Cancer > Cancer : sein	Gouvernance institutionnelle > Assurer la représentation au sein des organes consultatifs gouvernementaux	100	Regional	Regularly	119037236943
... The organization's flagship event - the annual Indo US Bridging RARE Summit brings together rare disease stakeholders, including scientists, patient advocates, government officials, biopharma executives, and policy experts who share a common goal: transforming the future of care for the 400 million people worldwide living with rare diseases.	Rare > Maladies rares : la plupart des types	Gouvernance institutionnelle > Travailler efficacement au sein de réseaux multi-parties prenantes	100	International	Regularly	119038170136
Serve on the Alliance for Breast Cancer Policy [The Alliance for Breast Cancer Policy is a coalition of over 25 national patient advocacy organizations founded by Susan G. Komen. The network unites advocates, community members, and industry partners to drive federal policy changes that improve access to care, eliminate out-of-pocket costs, and improve outcomes]. We were just part of a manuscript written for the launch of the global Breast Cancer Care Quality Index: https://www.mdpi.com/1660-4601/23/2/207	Cancer > Cancer : sein	Gouvernance institutionnelle > Travailler efficacement au sein de réseaux multi-parties prenantes	100 000	International	Sometimes	119052475951
We are not a lobbying organization, we are a 501 c-3 non-profit public charity. We sign on to letters with partner societies who are lobbying for better access to care. We host roundtables and advocacy awareness days with legislators where we raise awareness of current problems and offer solutions. One recent event was with the Governor of Virginia. We are planning a Spine Health Fair at the US Capitol in September.	Santé générale > Mode de vie	Gouvernance institutionnelle > Travailler efficacement au sein de réseaux multi-parties prenantes	100 000	National	Sometimes	119074217249
We are typically advisors on ICER [Institute for Clinical and Economic Review] reviews, active in Lupus Caucus, convene MAPRx [Medicare Access for Patients Rx] for Medicare Part D, etc.[MAPRx is guided by the idea that every Medicare Part D beneficiary should have timely, affordable access to the medications they need to live a healthy life.]	Rhumatismal > Lupus	Gouvernance institutionnelle > Travailler efficacement au sein de réseaux multi-parties prenantes	100 000	National	Regularly	119082751826

États-Unis

Résultats de l'enquête

Voix des groupes de patients

Objectifs des groupes de patients

Comment les groupes de patients interagissent avec les régulateurs de médicaments

Comment les groupes de patients obtiennent l'accès aux médicaments

Accéder aux résultats complets

Télécharger des exemples de rapports